| Pathway ID | hsa04015 |
| Pathway Term | Rap1 signaling pathway |
| Pathway Source | KEGG |
| Gene Symbol | Description | Entrez ID | Uniprot ID | Chromosomal Location |
|---|---|---|---|---|
|
AKT3 |
v-akt murine thymoma viral oncogene homolog 3 |
10000 |
Q9Y243 |
chr1: 243,488,233-243,851,079 |
|
RASGRP2 |
RAS guanyl releasing protein 2 (calcium and DAG-regulated) |
10235 |
Q7LDG7 |
chr11: 64,726,911-64,745,456 |
|
ADCY3 |
adenylate cyclase 3 |
109 |
O60266 |
chr2: 24,819,169-24,919,839 |
|
RAPGEF4 |
Rap guanine nucleotide exchange factor 4 |
11069 |
Q8WZA2 |
chr2: 172,735,274-173,052,893 |
|
ADCY7 |
adenylate cyclase 7 |
113 |
P51828 |
chr16: 50,246,137-50,318,135 |
|
ADCY9 |
adenylate cyclase 9 |
115 |
O60503 |
chr16: 3,953,387-4,116,185 |
|
CNR1 |
cannabinoid receptor 1 (brain) |
1268 |
P21554 |
chr6: 88,139,864-88,166,359 |
|
ADORA2B |
adenosine A2b receptor |
136 |
P29275 |
chr17: 15,944,917-15,975,746 |
|
CRKL |
v-crk avian sarcoma virus CT10 oncogene homolog-like |
1399 |
P46109 |
chr22: 20,917,426-20,953,749 |
|
MAPK14 |
mitogen-activated protein kinase 14 |
1432 |
Q16539 |
chr6: 36,027,677-36,111,236 |
|
CSF1R |
colony stimulating factor 1 receptor |
1436 |
P07333 |
chr5: 150,053,291-150,113,372 |
|
CTNNB1 |
catenin beta 1 |
1499 |
P35222 |
chr3: 41,194,837-41,260,096 |
|
CTNND1 |
catenin delta 1 |
1500 |
O60716 |
chr11: 57,753,243-57,819,546 |
|
DRD2 |
dopamine receptor D2 |
1813 |
P14416 |
chr11: 113,409,615-113,475,691 |
|
EFNA1 |
ephrin-A1 |
1942 |
P20827 |
chr1: 155,127,460-155,134,857 |
|
EFNA4 |
ephrin-A4 |
1945 |
P52798 |
chr1: 155,063,731-155,069,553 |
|
EFNA5 |
ephrin-A5 |
1946 |
P52803 |
chr5: 107,376,889-107,670,895 |
|
EGFR |
epidermal growth factor receptor |
1956 |
P00533 |
chr7: 55,019,021-55,211,628 |
|
AKT1 |
v-akt murine thymoma viral oncogene homolog 1 |
207 |
P31749 |
chr14: 104,769,349-104,795,751 |
|
AKT2 |
v-akt murine thymoma viral oncogene homolog 2 |
208 |
P31751 |
chr19: 40,230,317-40,285,536 |
|
F2R |
coagulation factor II (thrombin) receptor |
2149 |
P25116 |
chr5: 76,716,043-76,735,781 |
|
FGF2 |
fibroblast growth factor 2 (basic) |
2247 |
P09038 |
chr4: 122,826,708-122,898,236 |
|
FGF7 |
fibroblast growth factor 7 |
2252 |
P21781 |
chr15: 49,423,096-49,488,775 |
|
FGF9 |
fibroblast growth factor 9 |
2254 |
P31371 |
chr13: 21,671,383-21,704,498 |
|
FGF11 |
fibroblast growth factor 11 |
2256 |
Q92914 |
chr17: 7,438,273-7,444,937 |
|
FGF12 |
fibroblast growth factor 12 |
2257 |
P61328 |
chr3: 192,139,395-192,767,764 |
|
FGF13 |
fibroblast growth factor 13 |
2258 |
Q92913 |
chrX: 138,614,731-139,222,777 |
|
FGF14 |
fibroblast growth factor 14 |
2259 |
Q92915 |
chr13: 101,710,804-102,402,457 |
|
FGFR1 |
fibroblast growth factor receptor 1 |
2260 |
P11362 |
chr8: 38,411,138-38,468,834 |
|
FGFR2 |
fibroblast growth factor receptor 2 |
2263 |
P21802 |
chr10: 121,478,334-121,598,458 |
|
PLCB1 |
phospholipase C beta 1 |
23236 |
Q9NQ66 |
chr20: 8,077,251-8,968,360 |
|
FLT4 |
fms-related tyrosine kinase 4 |
2324 |
P35916 |
chr5: 180,601,506-180,649,624 |
|
FPR1 |
formyl peptide receptor 1 |
2357 |
P21462 |
chr19: 51,745,172-51,804,110 |
|
FYB |
FYN binding protein |
2533 |
O15117 |
chr5: 39,105,236-39,274,528 |
|
PRKD2 |
protein kinase D2 |
25865 |
Q9BZL6 |
chr19: 46,674,275-46,717,127 |
|
GNAI1 |
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 1 |
2770 |
P63096 |
chr7: 80,133,955-80,219,402 |
|
GNAI2 |
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 2 |
2771 |
P04899 |
chr3: 50,226,292-50,259,355 |
|
GNAI3 |
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 3 |
2773 |
P08754 |
chr1: 109,548,611-109,618,321 |
|
GNAQ |
guanine nucleotide binding protein (G protein), q polypeptide |
2776 |
P50148 |
chr9: 77,716,087-78,031,458 |
|
GNAS |
GNAS complex locus |
2778 |
O95467 |
chr20: 58,839,718-58,911,192 |
|
ANGPT1 |
angiopoietin 1 |
284 |
Q15389 |
chr8: 107,249,482-107,498,055 |
|
ANGPT2 |
angiopoietin 2 |
285 |
O15123 |
chr8: 6,499,651-6,563,409 |
|
RAPGEF1 |
Rap guanine nucleotide exchange factor 1 |
2889 |
Q13905 |
chr9: 131,576,770-131,740,074 |
|
GRIN2A |
glutamate receptor, ionotropic, N-methyl D-aspartate 2A |
2903 |
Q12879 |
chr16: 9,753,404-10,182,754 |
|
HGF |
hepatocyte growth factor (hepapoietin A; scatter factor) |
3082 |
P14210 |
chr7: 81,699,006-81,770,438 |
|
ID1 |
inhibitor of DNA binding 1, dominant negative helix-loop-helix protein |
3397 |
P41134 |
chr20: 31,605,283-31,606,515 |
|
IGF1 |
insulin like growth factor 1 |
3479 |
P05019 |
chr12: 102,395,867-102,480,645 |
|
IGF1R |
insulin like growth factor 1 receptor |
3480 |
P08069 |
chr15: 98,648,971-98,964,530 |
|
INS |
insulin |
3630 |
P01308 |
chr11: 2,159,779-2,161,341 |
|
INSR |
insulin receptor |
3643 |
P06213 |
chr19: 7,112,255-7,294,034 |
|
ITGAM |
integrin subunit alpha M |
3684 |
P11215 |
chr16: 31,259,990-31,332,892 |
|
ITGB1 |
integrin subunit beta 1 |
3688 |
P05556 |
chr10: 32,900,319-33,005,792 |
|
ITGB2 |
integrin subunit beta 2 |
3689 |
P05107 |
chr21: 44,885,953-44,931,989 |
|
ITGB3 |
integrin subunit beta 3 |
3690 |
P05106 |
chr17: 47,253,846-47,311,816 |
|
KIT |
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog |
3815 |
P10721 |
chr4: 54,657,918-54,740,715 |
|
KRAS |
Kirsten rat sarcoma viral oncogene homolog |
3845 |
P01116 |
chr12: 25,204,789-25,250,936 |
|
RHOA |
ras homolog family member A |
387 |
P61586 |
chr3: 49,359,145-49,412,998 |
|
MET |
MET proto-oncogene, receptor tyrosine kinase |
4233 |
P08581 |
chr7: 116,672,390-116,798,386 |
|
KITLG |
KIT ligand |
4254 |
P21583 |
chr12: 88,492,793-88,580,851 |
|
NGF |
nerve growth factor (beta polypeptide) |
4803 |
P01138 |
chr1: 115,285,918-115,338,236 |
|
NGFR |
nerve growth factor receptor |
4804 |
P08138 |
chr17: 49,495,293-49,515,017 |
|
NRAS |
neuroblastoma RAS viral (v-ras) oncogene homolog |
4893 |
P01111 |
chr1: 114,704,469-114,716,894 |
|
PARD6A |
par-6 family cell polarity regulator alpha |
50855 |
Q9NPB6 |
chr16: 67,660,946-67,662,778 |
|
PDGFA |
platelet-derived growth factor alpha polypeptide |
5154 |
P04085 |
chr7: 497,258-520,296 |
|
PDGFB |
platelet-derived growth factor beta polypeptide |
5155 |
P01127 |
chr22: 39,223,359-39,244,751 |
|
PDGFRA |
platelet-derived growth factor receptor, alpha polypeptide |
5156 |
P16234 |
chr4: 54,229,097-54,298,247 |
|
PDGFRB |
platelet-derived growth factor receptor, beta polypeptide |
5159 |
P09619 |
chr5: 150,113,837-150,155,872 |
|
RAPGEF6 |
Rap guanine nucleotide exchange factor 6 |
51735 |
Q8TEU7 |
chr5: 131,423,921-131,635,236 |
|
PFN1 |
profilin 1 |
5216 |
P07737 |
chr17: 4,945,652-4,949,061 |
|
PGF |
placental growth factor |
5228 |
P49763 |
chr14: 74,941,834-74,955,784 |
|
PIK3CA |
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha |
5290 |
P42336 |
chr3: 179,148,114-179,240,093 |
|
PIK3CB |
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta |
5291 |
P42338 |
chr3: 138,652,699-138,834,938 |
|
PIK3CD |
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta |
5293 |
O00329 |
chr1: 9,651,732-9,729,114 |
|
PIK3R1 |
phosphoinositide-3-kinase regulatory subunit 1 |
5295 |
P27986 |
chr5: 68,215,720-68,301,821 |
|
PRKCA |
protein kinase C, alpha |
5578 |
P17252 |
chr17: 66,302,636-66,810,743 |
|
PRKCB |
protein kinase C, beta |
5579 |
P05771 |
chr16: 23,836,001-24,220,611 |
|
PRKCI |
protein kinase C, iota |
5584 |
P41743 |
chr3: 170,222,365-170,305,981 |
|
PRKD1 |
protein kinase D1 |
5587 |
Q15139 |
chr14: 29,576,479-30,191,898 |
|
MAPK1 |
mitogen-activated protein kinase 1 |
5594 |
P28482 |
chr22: 21,754,500-21,867,680 |
|
MAPK3 |
mitogen-activated protein kinase 3 |
5595 |
P27361 |
chr16: 30,114,105-30,123,506 |
|
MAPK13 |
mitogen-activated protein kinase 13 |
5603 |
O15264 |
chr6: 36,127,809-36,144,524 |
|
PDGFC |
platelet derived growth factor C |
56034 |
Q9NRA1 |
chr4: 156,760,454-156,971,394 |
|
MAP2K1 |
mitogen-activated protein kinase kinase 1 |
5604 |
Q02750 |
chr15: 66,386,817-66,492,312 |
|
MAP2K2 |
mitogen-activated protein kinase kinase 2 |
5605 |
P36507 |
chr19: 4,090,321-4,124,129 |
|
MAP2K6 |
mitogen-activated protein kinase kinase 6 |
5608 |
P52564 |
chr17: 69,414,698-69,543,331 |
|
PARD3 |
par-3 family cell polarity regulator |
56288 |
Q8TEW0 |
chr10: 34,109,560-34,815,325 |
|
SIPA1L2 |
signal-induced proliferation-associated 1 like 2 |
57568 |
Q9P2F8 |
chr1: 232,397,965-232,561,558 |
|
RAC1 |
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) |
5879 |
P63000 |
chr7: 6,374,523-6,403,977 |
|
RAC2 |
ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) |
5880 |
P15153 |
chr22: 37,225,261-37,244,448 |
|
RAC3 |
ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3) |
5881 |
P60763 |
chr17: 82,031,624-82,034,204 |
|
RAF1 |
Raf-1 proto-oncogene, serine/threonine kinase |
5894 |
P04049 |
chr3: 12,583,601-12,664,226 |
|
RALA |
v-ral simian leukemia viral oncogene homolog A (ras related) |
5898 |
P11233 |
chr7: 39,623,483-39,708,124 |
|
RALB |
v-ral simian leukemia viral oncogene homolog B |
5899 |
P11234 |
chr2: 120,240,064-120,294,713 |
|
RALGDS |
ral guanine nucleotide dissociation stimulator |
5900 |
Q12967 |
chr9: 133,097,720-133,149,334 |
|
RAP1A |
RAP1A, member of RAS oncogene family |
5906 |
P62834 |
chr1: 111,542,218-111,716,691 |
|
ACTB |
actin, beta |
60 |
P60709 |
chr7: 5,527,151-5,563,784 |
|
RRAS |
related RAS viral (r-ras) oncogene homolog |
6237 |
P10301 |
chr19: 49,635,292-49,640,201 |
|
ARAP3 |
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3 |
64411 |
Q8WWN8 |
chr5: 141,653,401-141,682,221 |
|
TEK |
TEK tyrosine kinase, endothelial |
7010 |
Q02763 |
chr9: 27,109,141-27,230,175 |
|
THBS1 |
thrombospondin 1 |
7057 |
P07996 |
chr15: 39,581,079-39,599,466 |
|
TIAM1 |
T-cell lymphoma invasion and metastasis 1 |
7074 |
Q13009 |
chr21: 31,118,416-31,559,977 |
|
TLN1 |
talin 1 |
7094 |
Q9Y490 |
chr9: 35,696,948-35,732,395 |
|
ACTG1 |
actin gamma 1 |
71 |
P63261 |
chr17: 81,509,971-81,523,847 |
|
VEGFA |
vascular endothelial growth factor A |
7422 |
P15692 |
chr6: 43,770,184-43,786,487 |
|
VEGFB |
vascular endothelial growth factor B |
7423 |
P49765 |
chr11: 64,234,538-64,238,793 |
|
VEGFC |
vascular endothelial growth factor C |
7424 |
P49767 |
chr4: 176,683,538-176,792,727 |
|
PDGFD |
platelet derived growth factor D |
80310 |
Q9GZP0 |
chr11: 103,907,186-104,164,379 |
|
CALM2 |
calmodulin 2 |
805 |
P62158 |
chr2: 47,160,082-47,176,601 |
|
CALM3 |
calmodulin 3 |
808 |
P62158 |
chr14: 90,396,502-90,408,261 |
|
RASSF5 |
Ras association (RalGDS/AF-6) domain family member 5 |
83593 |
Q8WWW0 |
chr1: 206,507,530-206,589,448 |
|
PARD6B |
par-6 family cell polarity regulator beta |
84612 |
Q9BYG5 |
chr20: 50,731,544-50,756,795 |
|
FGF18 |
fibroblast growth factor 18 |
8817 |
O76093 |
chr5: 171,419,656-171,457,623 |
|
KRIT1 |
KRIT1, ankyrin repeat containing |
889 |
O00522 |
chr7: 92,198,969-92,246,166 |
|
CALML4 |
calmodulin like 4 |
91860 |
Q96GE6 |
chr15: 68,190,705-68,206,110 |
|
MAGI1 |
membrane associated guanylate kinase, WW and PDZ domain containing 1 |
9223 |
Q96QZ7 |
chr3: 65,353,525-66,038,834 |
|
FARP2 |
FERM, ARH/RhoGEF and pleckstrin domain protein 2 |
9855 |
O94887 |
chr2: 241,356,243-241,494,841 |
|
MAGI2 |
membrane associated guanylate kinase, WW and PDZ domain containing 2 |
9863 |
Q86UL8 |
chr7: 78,017,057-79,453,574 |
|
FGF19 |
fibroblast growth factor 19 |
9965 |
O95750 |
chr11: 69,698,232-69,704,642 |
|
CDC42 |
cell division cycle 42 |
998 |
P60953 |
chr1: 22,052,627-22,092,946 |